Large‐scale quantitative clinical proteomics by label‐free liquid chromatography and mass spectrometry
Open Access
- 15 February 2009
- journal article
- Published by Wiley in Cancer Science
- Vol. 100 (3), 514-519
- https://doi.org/10.1111/j.1349-7006.2008.01055.x
Abstract
We previously reported the development of an integrated proteome platform, namely 2-Dimensional Image Converted Analysis of Liquid chromatography and mass spectrometry (2DICAL), for quantitative comparison of large peptide datasets generated by nano-flow liquid chromatography (LC) and mass spectrometry (MS). The key technology of 2DICAL was the precise adjustment of the retention time of LC by dynamic programming. In order to apply 2DICAL to clinical studies that require comparison of a large number of patient samples we further refined the calculation algorithm and increased the accuracy and speed of the peptide peak alignment using a greedy algorithm, which had been used for fast DNA sequence alignment. The peptide peaks of each sample with the same m/z were extracted every 1 m/z and displayed with along the horizontal axis. Here we report a precise comparison of more than 150,000 typtic peptide ion peaks derived from 70 serum samples (40 patients with uterine endometrial cancer and 30 controls). The levels of 49 MS peaks were found to differ significantly between cancer patients and controls (P < 0.01, Welch's t-test and interquartile range [IQR] of >40), and the differential expression and identification of selected three proteins was validated by immunoblotting. 2DICAL was is highly advantageous for large-scale clinical proteomics because of its simple procedure, high throughput, and quantification accuracy.Keywords
This publication has 29 references indexed in Scilit:
- Serum albumin‐associated peptides of patients with uterine endometrial cancerCancer Science, 2007
- Evaluation of Multiprotein Immunoaffinity Subtraction for Plasma Proteomics and Candidate Biomarker Discovery Using Mass SpectrometryMolecular & Cellular Proteomics, 2006
- Label-free Quantitative Proteomics Using Large Peptide Data Sets Generated by Nanoflow Liquid Chromatography and Mass SpectrometryMolecular & Cellular Proteomics, 2006
- Possible Detection of Pancreatic Cancer by Plasma Protein ProfilingCancer Research, 2005
- Proteomic analysis of sera from hepatocellular carcinoma patients after radiofrequency ablation treatmentProteomics, 2005
- Poly(ADP-Ribose) Polymerase-1 Is a Component of the Oncogenic T-Cell Factor-4/β-Catenin ComplexGastroenterology, 2005
- Clinical Characteristics of Prognostic Factors in Poorly Differentiated (G3) Endometrioid Adenocarcinoma in JapanJapanese Journal of Clinical Oncology, 2005
- Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. AdultsNew England Journal of Medicine, 2003
- Mass spectrometry-based proteomicsNature, 2003
- Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohortInternational Journal of Cancer, 2003